Globally, we are witnessing an ever-increasing disease burden associated with increasingly comorbid and ageing populations. Further, the impact of COVID-19 pandemic has underscored the importance of establishing a critical care system that is more budget-efficient, personalised and provide digitally enabled care across the NHS.
Developments in AI, genomics, glucose monitoring and delivery systems, applications, wearables, and smartphone technologies can help address some of these challenges. Innovative UK SMEs are contributing to major breakthroughs that will lead to improvements in the diabetes care pathway over the next few years. The report will look at market opportunities in diabetes care, highlights some of the innovative SMEs tackling this area and review the patent landscape.